Insulet: Insulet Gains 62.9% in a Year
PODD's shares rise on the back of its innovative Omnipod 5 system and impressive market expansion. However, the unfavorable macroeconomic scenario is concerning.
Read full article »
Insulet designs and develops tubeless insulin pump medical devices for the diabetic patients.
Read more